Supplementary Tables from Synergy Between VEGF/VEGFR Inhibitors and Chemotherapy Agents in the Phase I Clinic

Autor: David S. Hong, Funda Meric-Berstam, Lee M. Ellis, Razelle Kurzrock, Ralph G. Zinner, Jennifer Wheler, Vivek Subbiah, Sarina Piha-Paul, Aung Naing, Filip Janku, Siqing Fu, Gerald Falchook, Apostolia M. Tsimberidou, Debora De Melo Gagliato, Denis Leonardo F. Jardim, Kenneth Hess, Chad Tang
Rok vydání: 2023
DOI: 10.1158/1078-0432.22455473
Popis: Supplementary Tables. Supplemental Table 1: Frequency of specific MET, NRAS, and KRAS mutations Supplemental Table 2. Distribution of patients with BRAF mutations
Databáze: OpenAIRE